Looking for breakthrough ideas for innovation challenges? Try Patsnap Eureka!

Medicine composition for treating prostatitis

A prostatitis and composition technology, applied in the directions of drug combinations, pharmaceutical formulations, plant raw materials, etc., can solve the problems of long prostatitis cycle, ineffective anti-inflammatory and analgesic effects, etc., and achieves a short treatment cycle, reduces the total number of white blood cells, and reduces moisture content. The effect of heavy coefficients

Inactive Publication Date: 2016-03-23
QINGDAO HUAZHICAO PHARMA CO LTD
View PDF2 Cites 1 Cited by
  • Summary
  • Abstract
  • Description
  • Claims
  • Application Information

AI Technical Summary

Problems solved by technology

The drug has a curative effect in the treatment of chronic prostatitis, but the cycle of the drug treatment of prostatitis is long, and the effect in anti-inflammatory and analgesic is not very significant

Method used

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
View more

Image

Smart Image Click on the blue labels to locate them in the text.
Viewing Examples
Smart Image
  • Medicine composition for treating prostatitis
  • Medicine composition for treating prostatitis
  • Medicine composition for treating prostatitis

Examples

Experimental program
Comparison scheme
Effect test

Embodiment 1

[0035] The pharmaceutical composition of Example 1 of the present invention is made of the following raw materials in parts by weight: 10 parts of Artemisia argyi, 9 parts of Astragalus, 8 parts of Phellodendron Phellodendri, 8 parts of Rehmannia glutinosa, 3 parts of Kochia chinensis, 6 parts of Smilax versicolor, and 6 parts of Yunzhi , 3 parts of akebia, 3 parts of plantain, 2 parts of yam and 1 part of licorice.

[0036] The preparation method is as follows:

[0037] (1): Take mugwort leaves, wash, dry and crush them into coarse powder, place them in a supercritical carbon dioxide extraction device, add 75% ethanol with a volume fraction of 40% of the weight of the coarse powder, adjust the carbon dioxide flow rate to 15L / h, and extract The pressure is 15MPa, the extraction temperature is 50°C, the extraction time is 1.5h, and the extract of Artemisia argyi is obtained by separation under reduced pressure, and the residue of Artemisia argyi is kept;

[0038] (2): Take Ast...

Embodiment 2

[0042] The pharmaceutical composition of Example 2 of the present invention is made from the following raw materials in parts by weight: 20 parts of Artemisia argyi, 15 parts of Radix Astragali, 12 parts of Phellodendron Phellodendri, 12 parts of Rehmannia glutinosa, 6 parts of Kochia chinensis, 9 parts of Smilax cocos, and 9 parts of Yunzhi , 6 parts of Akebia, 4 parts of plantain, 4 parts of yam and 5 parts of licorice.

[0043] The preparation method is the same as in Example 1.

Embodiment 3

[0045] The pharmaceutical composition of Example 3 of the present invention is made from the following raw materials in parts by weight: 25 parts of Artemisia argyi, 20 parts of Radix Astragali, 15 parts of Phellodendron Phellodendri, 15 parts of Rehmannia glutinosa, 10 parts of Kochia scoparia, 12 parts of Smilax cocos, and 12 parts of Yunzhi , 8 parts of Akebia, 6 parts of plantain, 6 parts of yam and 10 parts of licorice.

[0046] The preparation method is the same as in Example 1.

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to View More

PUM

No PUM Login to View More

Abstract

The invention discloses a medicine composition for treating prostatitis, and belongs to the technical field of traditional Chinese medicine. The medicine composition is prepared from folium artemisiae argyi, astragalus membranaceus, golden cypress, dried rehamnnia roots, belvedere fruits, rhizoma smilacis glabrae, rainbow conk, akebiaquinata, plantain herb, Chinese yam and liquorice. According to the medicine composition, the total number of leukocytes in non-bacterial or bacterial prostatic fluid of a rat can be effectively decreased, the density of lecithin bodies in the prostatic fluid of the rat is increased, the wet weight coefficient of the rat gland is decreased, and the remarkable treatment effect on the prostatitis is achieved. The medicine composition further has the effects of clearing away heat and toxic materials and the like, and rehabilitation of a patient suffering from the prostatitis is facilitated.

Description

technical field [0001] The invention belongs to the technical field of traditional Chinese medicines, in particular to a pharmaceutical composition for treating prostatitis. Background technique [0002] In traditional Chinese medicine, prostatitis belongs to the category of "leaching syndrome" and "inflammation". Its etiology is complex and its symptoms are diverse. From the theory of TCM syndrome differentiation, the main etiology and pathogenesis of prostatitis and benign prostatic hyperplasia are caused by deficiency of kidney essence, qi stagnation and blood stasis, accumulation of heat and toxin, and damp-heat injection. Heat-clearing and toxic substances removing, inducing diuresis and treating stranguria syndrome, to achieve the purpose of treating both symptoms and root causes. The treatment of prostatitis with traditional Chinese medicine has the advantages of flexible syndrome differentiation, great freedom in exchanging prescriptions, treating the disease accord...

Claims

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to View More

Application Information

Patent Timeline
no application Login to View More
Patent Type & Authority Applications(China)
IPC IPC(8): A61K36/896A61K36/90A61P13/08
CPCA61K36/07A61K36/185A61K36/282A61K36/481A61K36/484A61K36/68A61K36/70A61K36/756A61K36/804A61K36/8945A61K36/896A61K36/90A61K2300/00
Inventor 刘学键
Owner QINGDAO HUAZHICAO PHARMA CO LTD
Who we serve
  • R&D Engineer
  • R&D Manager
  • IP Professional
Why Patsnap Eureka
  • Industry Leading Data Capabilities
  • Powerful AI technology
  • Patent DNA Extraction
Social media
Patsnap Eureka Blog
Learn More
PatSnap group products

Browse by: Latest US Patents, China's latest patents, Technical Efficacy Thesaurus, Application Domain, Technology Topic, Popular Technical Reports.

© 2024 PatSnap. All rights reserved.Legal|Privacy policy|Modern Slavery Act Transparency Statement|Sitemap|About US| Contact US: help@patsnap.com